// App-Quantinova.ai

: Adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma – factors affecting receipt and completion of chemotherapy

Researchers

Presenter

  • A. Sultana

Principal Investigators

  • J. Hodson

  • R. Marudanayagam

  • B. Dasari

  • P. Muiesan

  • D. Mirza

  • J. Isaac

  • R. Sutcliffe

  • Y.T. Ma

  • K. Roberts

Medical Centers

  • HPB Surgery and Liver Transplant, University Hospitals Birmingham NHS Foundation Trust, United Kingdom

  • Medical Statistics, University Hospitals Birmingham NHS Foundation Trust, United Kingdom

  • Medical Statistics, University Hospitals Birmingham NHS Foundation Trust, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreas ductal adenocarcinoma

  • Microphthalmia, syndromic, 9

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved